Alpha thalassaemia (Q39515): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:3A50.0
@@ Property / CURIE: CID11:3A50.0 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-3A50.0
@@ Property / Canary Token: dki-india-3A50.0 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+D56.0
@@ Property / Linked ICD 10: D56.0 / rank @@
+Normal rank

Latest revision as of 04:57, 13 August 2026

Alpha-thalassemia is an inherited haemoglobinopathy characterised by impaired synthesis of alpha-globin chains leading to a variable clinical picture depending on the number of affected alleles, and encompassing the alpha thalassaemia trait, haemoglobin H disease (HbH) and Bart's hydrops fetalis.

Language	Label	Description	Also known as
default for all languages	3A50.0
English	Alpha thalassaemia	Alpha-thalassemia is an inherited haemoglobinopathy characterised by impaired synthesis of alpha-globin chains leading to a variable clinical picture depending on the number of affected alleles, and encompassing the alpha thalassaemia trait, haemoglobin H disease (HbH) and Bart's hydrops fetalis.